#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac arrest Myeloproliferative neoplasm Congenital pseudarthrosis Hereditary motor and sensory neuropathy Follicular lymphoma High-grade B-cell lymphoma NTRK gene fusion overexpression Neurofibroma Glomerulonephritis Thyroid cancer metastatic Alpha-1 antitrypsin deficiency Chronic graft versus host disease in liver Anal cancer Fibrous dysplasia of bone Prostate cancer More trials…

    Learn about Rare Diseases

    Alport’s syndrome Andersen-Tawil syndrome – Treatment Paroxysmal nocturnal haemoglobinuria – Life with Disease Isodicentric chromosome 15 syndrome – Trials in Disease Cytokine release syndrome – Basic Information Focal segmental glomerulosclerosis – Basic Information Thrombotic thrombocytopenic purpura Hereditary optic atrophy Medulloblastoma recurrent – Basic Information Haemophagocytic lymphohistiocytosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dulaglutide Briquilimab Dorocubicel 204-NETU Doxycycline Hyclate NALOXEGOL Ketoprofen Lysine Solrikitug Zelicapavir Vosoritide Stro-002 Vgl101 Adg126 Peboctocogene Camaparvovec Mrna-3210 Evencaleucel Rusfertide Noradrenaline Tartrate Cat Epithelia Ceritinib More therapies…

    Learn about Your Condition

    Incontinence Vascular graft thrombosis Cervical dysplasia Sexual dysfunction Ventricular extrasystoles Plasma cell myeloma Malignant melanoma stage III Nasopharyngeal cancer Anal cancer stage II Traumatic pain Short stature Carotid artery stenosis Chorea Laparoscopic surgery Thrombotic microangiopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mantle cell lymphoma recurrent

  • A study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Glofitamab
    • Lenalidomide
    France Italy Spain Sweden

  • Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Follicular lymphoma stage II
    • Follicular lymphoma stage III
    • Marginal zone lymphoma refractory
    Investigated Drugs:
    • BGB-16673
    • Mosunetuzumab
    • Glofitamab
    Germany Italy Poland

  • Safety Study of Sonrotoclax and Zanubrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma recurrent
    • Mantle cell lymphoma refractory
    Investigated Drugs:
    • N-[4-({[(1R,4R)-4-Hydroxy-4-Methylcyclohexyl]Methyl}Amino)-3- Nitrobenzene-1-Sulfonyl]-4-(2-{(2S)-2-[2-(Propan-2-Yl)Phenyl]Pyrrolidin1-Yl}-7-Azaspiro[3.5]Nonan-7-Yl)-2-[(1H-Pyrrolo[2,3-B]Pyridin-5- Yl)Oxy]Benzamide
    • Zanubrutinib
    France

  • Study on Loncastuximab Tesirine for Patients with Relapsed or Refractory Mantle Cell Lymphoma After Immunochemotherapy with Rituximab, Bendamustine, and Cytarabine

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma recurrent
    • Mantle cell lymphoma refractory
    Investigated Drugs:
    • Loncastuximab Tesirine
    • Bendamustine Hydrochloride
    • Cytarabine
    Italy

  • Study on KTE-X19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma Responding Partially to Ibrutinib

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma recurrent
    • Mantle cell lymphoma refractory
    • Mantle cell lymphoma
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Brexucabtagene Autoleucel
    • Fludarabine
    Italy

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!